Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Treatment Effectiveness”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05065905
What this trial is testing

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

Who this might be right for
HIV CoinfectionAids/Hiv ProblemTuberculosis, Pulmonary+3 more
SPP Pharmaclon Ltd. 78
Large-scale testing (Phase 3)Study completedNCT00698334
What this trial is testing

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeTuberculosis
All India Institute of Medical Sciences 150
Not applicableActive Not RecruitingNCT07069387
What this trial is testing

Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence

Who this might be right for
Tuberculosis (TB)
University of Malaya 81
Not applicableNot Yet RecruitingNCT07479030
What this trial is testing

A Home-Based Approach to Tuberculosis Preventive Treatment Management

Who this might be right for
Tuberculosis
Dilla University 1,300
Early research (Phase 1)Study completedNCT00004736
What this trial is testing

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT04919239
What this trial is testing

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

Who this might be right for
Tuberculosis, Pulmonary
Archivel Farma S.L. 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03828201
What this trial is testing

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Boston University 271
Large-scale testing (Phase 3)Study completedNCT04721795
What this trial is testing

Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis
Obafemi Awolowo University Teaching Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00411996
What this trial is testing

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 20
Large-scale testing (Phase 3)Ended earlyNCT05327803
What this trial is testing

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung Disease
AN2 Therapeutics, Inc 177
Post-approval studies (Phase 4)UnknownNCT05306223
What this trial is testing

An Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Who this might be right for
Tuberculosis, Multidrug-Resistant
Beijing Chest Hospital 212
Not applicableStudy completedNCT01945905
What this trial is testing

Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in Colombia

Who this might be right for
Tuberculosis, Pulmonary
Fundación FES 264
Large-scale testing (Phase 3)Study completedNCT02563327
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Who this might be right for
Tuberculosis
Centers for Disease Control and Prevention 2,516
Post-approval studies (Phase 4)Study completedNCT00850915
What this trial is testing

Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya

Who this might be right for
Tuberculosis
KNCV Tuberculosis Foundation 1,259
Large-scale testing (Phase 3)Looking for participantsNCT05401071
What this trial is testing

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Who this might be right for
Tuberculosis, Pulmonary
Huashan Hospital 2,442
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07656012
What this trial is testing

Re-evaluating the Duration in Children of TB Treatment

Who this might be right for
Tuberculosis
University of Wisconsin, Madison 230
Not applicableStudy completedNCT07747792
What this trial is testing

Shorter Treatment Regimen Implementation Evaluation Study

Who this might be right for
Tuberculosis (TB)Tuberculosis in ChildrenTuberculosis Treatment Effectiveness+1 more
Centre for Infectious Disease Research in Zambia 175
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Testing effectiveness (Phase 2)WithdrawnNCT05136833
What this trial is testing

Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients

Who this might be right for
Tuberculosis
Archivel Farma S.L.
Next Page